05 Jul Exact Sciences riding high after rebounding from rough patch
Exact Sciences Corp.’s fortunes are on the upswing. Sales of its Cologuard test for colorectal cancer are on the rise, its stock is hitting record highs, and the company has padded its coffers with the sale of even more stock. Its new research and development...